Education, Research & Positions
Regulatory T cell therapy promotes TGF-β and IL-6-dependent pro-inflammatory Th17
Regulatory T cell therapy promotes TGF-β and IL-6-dependent pro-inflammatory Th17 cell generation by reducing IL-2 Summary Regulatory T cell (Treg) therapy, intended to suppress inflammation, can paradoxically trigger inflammatory responses in certain contexts. Research Read More
